Benzinga's Top Upgrades, Downgrades For January 24, 2018

Loading...
Loading...

Top Upgrades

  • Jefferies upgraded McKesson Corporation MCK from Hold to Buy. McKesson shares rose 1.55 percent to $173.25 in pre-market trading.
  • Morgan Stanley upgraded Energen Corporation EGN from Equal-Weight to Overweight. Energen fell 0.84 percent to $57.72 in pre-market trading.
  • Analysts at BMO Capital upgraded Berry Global Group Inc BERY from Market Perform to Outperform. Berry Global shares rose 1.37 percent to $59.03 in pre-market trading.
  • Stifel Nicolaus upgraded Casella Waste Systems Inc. CWST from Hold to Buy. Casella Waste Systems shares gained 0.37 percent to close at $24.26 on Tuesday.
  • Analysts at KeyBanc upgraded McDermott International Inc MDR from Sector Weight to Overweight. McDermott shares gained 4.96 percent to $8.25 in pre-market trading.
  • Analysts at Longbow Research upgraded Meritor Inc MTOR from Neutral to Buy. Meritor shares rose 4.7 percent to $24.95 in pre-market trading.
  • Macquarie upgraded Canadian National Railway (USA) CNI from Neutral to Outperform. Canadian National Railway shares gained 0.51 percent to close at $80.31 on Monday.
  • Analysts at Bank of America upgraded Louisiana-Pacific Corporation LPX from Underperform to Neutral. Louisiana-Pacific shares rose 0.24 percent to close at $37.82 on Monday.
  • Bank of America upgraded Weyerhaeuser Co WY from Neutral to Buy. Weyerhaeuser shares rose 1.12 percent to $37.02 in pre-market trading.


Top Downgrades

  • Analysts at Evercore ISI Group downgraded United Continental Holdings Inc UAL from Outperform to In-Line. United Continental shares fell 7.53 percent to $72.10 in pre-market trading.
  • Oppenheimer downgraded CEVA, Inc. CEVA from Outperform to Perform. CEVA shares rose 0.10 percent to close at $48.35 on Tuesday.
  • DZ Bank downgraded Visa Inc V from Buy to Hold. Visa shares rose 0.28 percent to close at $125.00 on Monday.
  • Argus downgraded Bioverativ Inc BIVV from Buy to Hold. Bioverativ shares fell 0.61 percent to close at $103.16 on Tuesday.
  • Mizuho downgraded PRA Health Sciences Inc PRAH from Buy to Neutral. PRA Health shares dropped 0.15 percent to close at $94.22 on Tuesday.
  • Barclays downgraded Juno Therapeutics Inc JUNO from Overweight to Equal-Weight. Juno Therapeutics shares fell 0.07 percent to $85.80 in pre-market trading.
  • Loop Capital downgraded Aaron's, Inc. AAN from Buy to Hold. Aaron's shares fell 1 percent to $41.69 in pre-market trading.
  • Analysts at Cowen & Co. downgraded Puma Biotechnology Inc PBYI from Outperform to Market Perform. Puma Biotechnology shares fell 27.89 percent to $65.55 in pre-market trading.
  • Morgan Stanley downgraded Encana Corp (USA) ECA from Overweight to Equal-Weight. Encana shares rose 0.37 percent to $13.60 in pre-market trading.
  • JMP Securities downgraded Jones Lang LaSalle Inc JLL from Market Outperform to Market Perform. Jones Lang LaSalle shares rose 0.10 percent to close at $156.14 on Monday.


Top Initiations

  • Goldman Sachs initiated coverage on Valeant Pharmaceuticals Intl Inc VRX with a Sell rating. The price target for Valeant is set to $18. Valeant shares closed at $22.30 on Tuesday.
  • Taglich Brothers initiated coverage on Borqs Technologies, Inc. BRQS with a Speculative Buy rating. Borqs Technologies shares closed at $6.45 on Tuesday.
  • Nomura initiated coverage on Red Hat Inc RHT with a Buy rating. The price target for Red Hat is set to $152. Red Hat shares closed at $128.15 on Tuesday.
  • SunTrust Robinson Humphrey initiated coverage on Trivago NV - ADR TRVG with a Hold rating. Trivago shares closed at $7.65 on Tuesday.
  • Analysts at Nomura initiated coverage on Microsoft Corporation MSFT with a Buy rating. The price target for Microsoft is set to $102. Microsoft shares closed at $91.90 on Tuesday.
  • Analysts at Jefferies initiated coverage on HollyFrontier Corp HFC with an Underperform rating. The price target for HollyFrontier is set to $40. HollyFrontier shares closed at $51.72 on Tuesday.
  • Nomura initiated coverage on Oracle Corporation ORCL with a Buy rating. The price target for Oracle is set to $64. Oracle shares closed at $51.12 on Tuesday.
  • Analysts at Goldman Sachs initiated coverage on Halozyme Therapeutics, Inc. HALO with a Neutral rating. The price target for Halozyme Therapeutics is set to $20. Halozyme Therapeutics shares closed at $19.68 on Tuesday.
Loading...
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: UpgradesDowngradesInitiationPre-Market OutlookAnalyst RatingsForest ProductsHealth CareHealth Care DistributorsInitiationsMaterialstop upgrades
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...